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Herpes simplex virus (HSV) is a major opportunistic pathogen in immunosuppressed 
patients and a serious disease in high human immunodeficiency virus (HIV)/ acquired 
immunodeficiency syndrome (AIDS) prevalence areas.  The existence of resistant strains 
to the available drug is therefore an urgent need to identify new alternative agents for 
HSV.  The aim of this study is to investigate anti-viral activities of the plants.  Assays 
were developed to determine the characteristics of anti-viral activities, as anti-viral 
attachment, anti-prophylactic and virucidal.  The pseudorabies virus (PrV) has been used 
as representative of HSV.  Three medicinal plants have been used, which is Centella 
asiatica L. (C. asiatica), Strobilanthes crispus L. (S. crispus) and Curcuma longa L. (C. 
longa).  The plants are reputed in traditional medicine for many treatments of diseases.  
Firstly, the potential cytotoxicity was evaluated for plant methanol extracts (ME) and 
aqueous extracts (AE) in cell line by using MTT assay.  All three plant extracts were 
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found significantly (P < 0.05) non cytotoxic towards African Green Monkey Kidney 
(Vero) cells, Baby Hamster Kidney (BHK) cells and Rabbit Kidney (RK) cells.  The 
plant ME was generally more cytotoxic than AE, showed lower (76 µg/ml) non-toxic 
limit concentration (NTLC50) than plant AE (82 µg/ml).  The least cytotoxic was the 
extract of S. crispus followed by C. asiatica and C. longa.  The resistance of three 
different cell lines was also compared and it showed the BHK cells were the most 
toughest and resistant to the plant extracts.  In anti-viral analysis, it was discovered that 
all plant extracts showed marked prophylactic activity, considerable anti-attachment and 
virucidal abilities up to 75% inhibition of cytopathic effect (CPE) formation.  The C. 
longa extract was found as a potent anti-viral agent followed by S. crispus and C. 
asiatica.  It exerted better prophylactic activity against PrV compared to the other two 
plants. Whereas S. crispus was found very effective as virucidal agent while C. asiatica 
as anti-viral attachment agent.  Based on the results, it was also found that plant ME 
possessed better anti-viral activity than plant AE.  These results also showed each of 
three plants possessed different anti-viral activities. The anti-viral activities were also 
varies in different cell lines tested.  All three plants were analysed by liquid 
chromatography-electrospray ionisation-mass spectrometry (LC-ESI-MS) to identify 
plant compounds.  The analysis revealed several compounds in C. asiatica, S. crispus and 
C. longa ME.  This study discovered the promising anti-viral activities of C. asiatica, S. 
crispus and C. longa but not any identified plant compound against PrV in vitro.  These 
results suggest that all three plant extracts have potent anti-viral agents against PrV as 
representative of HSV that can be exploited for development of an alternative medicine 
to prevent HSV infections.   
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
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Herpes simplex virus (HSV) adalah patogen oportunis utama kepada pesakit-pesakit yang 
sistem imunnya ditekan dan adalah satu penyakit serius di kawasan yang lazimnya 
mempunyai perebakan Virus Kurang Daya Tahan Penyakit (HIV) atau Sindrom Kurang 
Daya Tahan Penyakit (AIDS) yang tinggi.  Kewujudan strain virus yang rintang kepada 
ubatan anti-virus menyebabkan keperluan mendesak untuk mencari agen alternatif bagi 
merawat HSV.  Tujuan kajian ini adalah untuk mengkaji aktiviti anti-virus oleh 
tumbuhan.  Kaedah-kaedah untuk menentukan sifat dan ciri aktiviti anti-virus 
pseudorabies (PrV) iaitu anti-perlekatan, anti-pre-rawatan dan membunuh virus telah 
dijalankan.  PrV telah digunakan sebagai mewakili HSV.  Tiga tumbuhan ubatan telah 
digunakan iaitu Centella asiatica L. (C. asiatica), Strobilanthes crispus L. (S. crispus) 
dan Curcuma longa L. (C. longa).  Tumbuhan-tumbuhan ini mempunyai reputasi yang 
baik dalam merawat pelbagai penyakit di dalam perubatan tradisional.  Pertama, potensi 
toksik ekstrak methanol (EM) and ekstrak akuas (EA) tumbuhan telah dianalisa ke atas 
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barisan sel dengan menggunakan kaedah MTT.  Kesemua ekstrak tumbuhan dijumpai 
signifikan (p < 0.05) tidak menyebabkan toksik kepada sel Buah Pinggang Monyet Hijau 
(Vero), sel Buah Pinggang Anak Hamster (BHK) dan sel Buah Pinggang Arnab (RK).  
Secara amnya, EM tumbuhan lebih toksik ke atas sel berbanding AE tumbuhan, 
menunjukkan kepekatan tidak toksik pada 50% yang lebih rendah (76 µg/ml) daripada 
AE tumbuhan (85 µg/ml).  Kerintangan ketiga-tiga barisan sel terhadap ekstrak tumbuhan 
juga dibandingkan dan menunjukkan sel BHK adalah paling kuat dan rintang kepada 
ekstrak tumbuhan.  Kesemua ekstrak tumbuhan menunjukkan kebolehan yang jelas 
aktiviti pre-rawatan manakala anti-perlekatan dan kebolehan membunuh virus yang boleh 
dipertimbangkan sehingga 75% penekanan ke atas pembentukan Kesan Saitopatik (CPE).  
Ekstrak C. longa telah dijumpai sebagai agen anti-viral yang sangat berpotensi, diikuti 
ekstrak S. crispus dan C. asiatica.  Ia menunjukkan aktiviti pre-rawatan yang lebih baik 
ke atas PrV berbanding dua tumbuhan tersebut.  Manakala ekstrak S. crispus telah 
dijumpai menunjukkan kesan efektif sebagai agen membunuh virus dan ekstrak C. 
asiatica sebagai agen anti-perlekatan.  Berdasarkan kepada keputusan, ia menunjukkan 
ME tumbuhan memberikan aktiviti anti-virus yang lebih baik berbanding AE tumbuhan.  
Keputusan juga menunjukkan bahawa setiap tumbuhan memberikan aktiviti anti-virus 
yang berbeza.  Aktiviti anti-virus juga berbeza di dalam barisan sel yang berbeza.  
Ketiga-tiga tumbuhan telah dianalisa dengan menggunakan kromatografi cecair-ionisasi 
elektrospray-spektrometer jisim (LC-ESI-MS) untuk mengenalpasti bahan tumbuhan. 
Analisa tersebut mendedahkan bahan-bahan yang terkandung di dalam C. asiatica, S. 
crispus dan C. longa EM.  Kajian ini menemui aktiviti anti-virus bagi C. asiatica, S. 
crispus dan C. longa tetapi bukan daripada mana-mana bahan tumbuhan yang 
 6
 7
dikenalpasti terhadap PrV secara in vitro.  Keputusan kajian juga mencadangkan bahawa 
ketiga-tiga tumbuhan mempunyai potensi sebagai agen anti-virus ke atas PrV sebagai 
mewakili HSV yang boleh dieksploitasikan bagi pembangunan ubatan alternatif bagi 
menghalang jangkitan HSV. 
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CHAPTER I 
 
INTRODUCTION 
 
Viral Infections 
 
Viral infections are major health problem all over the world due to their morbidity and 
mortality.  There are many types of transmissions of viral infections in man.  They are 
respiratory or salivary spread, which is not readily controllable; faecal-oral spread that is 
controllable by public health measures and venereal spread, which is socially difficult to 
control.  An example is HSV (Dawn and Robert, 1997).   
  
The immune system appears as the controlling factor within the host that maintains 
beneficial microbes at harmless levels and prevents infections by dangerous agents.  It is 
able to combat a variety of infections from birth on.  Evolutionary pressure has forced 
most viruses to develop many strategies to subvert the immune system.  Some of them 
are production of antigenic variants; adopted by influenza virus and HIV, avoiding 
recognition by lymphocytes; for example adenovirus, manipulate cytokine pathways to 
avoid destruction by the host immune response, the production of materials that interfere 
with the production of pro-inflammatory cytokines; for example vaccinia and cowpox 
viruses, and interfering with the alternate pathways of complement activation; for 
example HSV (Hans et al., 2000; Bruce, 2002).  
 
